Kei Ogata

A significant reduction in serum alanine aminotransferase levels after 3-month iron reduction therapy for chronic hepatitis C: a multicenter, prospective, randomized, controlled trial in Japan

Motoyoshi Yano, Hisao Hayashi, Kentaro Yoshioka et al. · Journal of Gastroenterology · 2004 · 63 citations

Medicine, Pharmacotherapy, Hepatology +13

Risk factors for hepatocellular carcinoma in Japanese patients with autoimmune hepatitis type 1

Teruko Hino-Arinaga, Tatsuya Ide, Ryoko Kuromatsu et al. · Journal of Gastroenterology · 2011 · 42 citations

Medicine, Immunology, Oncology +12

An analysis of drug-induced liver injury, which showed histological findings similar to autoimmune hepatitis

Akiko Hisamochi, Masayoshi Kage, Tatsuya Ide et al. · Journal of Gastroenterology · 2015 · 38 citations · Full text

Medicine, Pharmacology, Toxicology +14

A Randomized Study of Extended Treatment With Peginterferon α-2b Plus Ribavirin Based on Time to HCV RNA Negative–Status in Patients With Genotype 1b Chronic Hepatitis C

Tatsuya Ide, Teruko Hino, Kei Ogata et al. · The American Journal of Gastroenterology · 2008 · 34 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Survival Benefit of Hepatic Arterial Infusion Chemotherapy over Sorafenib in the Treatment of Locally Progressed Hepatocellular Carcinoma

Hideki Iwamoto, Takashi Niizeki, Hiroaki Nagamatsu et al. · Cancers · 2021 · 32 citations · Full text

Medicine, Oncology, Pharmacology +14